Moderna asking for full FDA approval of its COVID vaccine
WASHINGTON / CNBC — Moderna officials asked the Food and Drug Administration to fully approve it’s coronavirus vaccine on Tuesday, making it the second drugmaker in the U.S. to do so. If approved, Moderna would be able to market their vaccine directly to consumers. The mRNA vaccine is currently on the U.S. market under an emergency use authorization, which was granted by the FDA in December. It gives conditional approval based on two months of safety data. It’s not the same as a biologics license application, or a request for full approval, which requires at least six months of...